Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1985 |
|---|---|
| Identifier | NCT04151225 |
| Trial Title | Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohns Disease|Crohn's Disease |
| Interventions | DRUG: GSK2330811|DRUG: Placebo |
Participant Information
| Sponsor | GlaxoSmithKline |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2021-04-05 |
|---|---|
| Primary Completion Date | 2024-04-22 |
| Completion Date | 2025-05-26 |